Richard James Whitley - Net Worth and Insider Trading
Richard James Whitley Net Worth
The estimated net worth of Richard James Whitley is at least $2 Million dollars as of 2024-09-20. Richard James Whitley is the Director of Gilead Sciences Inc and owns about 25,135 shares of Gilead Sciences Inc (GILD) stock worth over $2 Million. Richard James Whitley is also the Director of Virios Therapeutics Inc and owns about 700 shares of Virios Therapeutics Inc (VIRI) stock worth over $144. Details can be seen in Richard James Whitley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard James Whitley has not made any transactions after 2022-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard James Whitley
Richard James Whitley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard James Whitley owns 2 companies in total, including Gilead Sciences Inc (GILD) , and Virios Therapeutics Inc (VIRI) .
Click here to see the complete history of Richard James Whitley’s form 4 insider trades.
Insider Ownership Summary of Richard James Whitley
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GILD | Gilead Sciences Inc | 2019-05-01 | director |
VIRI | Virios Therapeutics Inc | 2022-12-08 | director |
Richard James Whitley Latest Holdings Summary
Richard James Whitley currently owns a total of 2 stocks. Among these stocks, Richard James Whitley owns 25,135 shares of Gilead Sciences Inc (GILD) as of May 1, 2019, with a value of $2 Million and a weighting of 99.99%. Richard James Whitley also owns 700 shares of Virios Therapeutics Inc (VIRI) as of December 8, 2022, with a value of $144 and a weighting of 0.01%.
Latest Holdings of Richard James Whitley
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 2019-05-01 | 25,135 | 83.41 | 2,096,510 |
VIRI | Virios Therapeutics Inc | 2022-12-08 | 700 | 0.21 | 144 |
Holding Weightings of Richard James Whitley
Richard James Whitley Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard James Whitley has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 9,534 shares on May 1, 2019, which brought Richard James Whitley around $619,901.
According to the SEC Form 4 filings, Richard James Whitley has made a total of 3 transactions in Virios Therapeutics Inc (VIRI) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Virios Therapeutics Inc is the sale of 1,800 shares on December 8, 2022, which brought Richard James Whitley around $468.
Insider Trading History of Richard James Whitley
- 1
Richard James Whitley Trading Performance
GuruFocus tracks the stock performance after each of Richard James Whitley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard James Whitley is -13.69%. GuruFocus also compares Richard James Whitley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard James Whitley within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard James Whitley's insider trading performs compared to the benchmark.
Performance of Richard James Whitley
Richard James Whitley Ownership Network
Richard James Whitley Owned Company Details
What does Gilead Sciences Inc do?
Who are the key executives at Gilead Sciences Inc?
Richard James Whitley is the director of Gilead Sciences Inc. Other key executives at Gilead Sciences Inc include Chief Medical Officer Merdad Parsey , Chief Commercial Officer Johanna Mercier , and EVP & Chief Financial Officer Andrew D Dickinson .
Gilead Sciences Inc (GILD) Insider Trades Summary
Over the past 18 months, Richard James Whitley made no insider transaction in Gilead Sciences Inc (GILD). Other recent insider transactions involving Gilead Sciences Inc (GILD) include a net sale of 38,462 shares made by Merdad Parsey , a net sale of 52,602 shares made by Johanna Mercier , and a net sale of 15,000 shares made by Andrew D Dickinson .
In summary, during the past 3 months, insiders sold 67,606 shares of Gilead Sciences Inc (GILD) in total and bought 0 shares, with a net sale of 67,606 shares. During the past 18 months, 106,064 shares of Gilead Sciences Inc (GILD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 106,064 shares.
Gilead Sciences Inc (GILD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gilead Sciences Inc Insider Transactions
Richard James Whitley Mailing Address
Above is the net worth, insider trading, and ownership report for Richard James Whitley. You might contact Richard James Whitley via mailing address: Uab, Chb 303, 1600 7th Avenue South, Birmingham Al 35233-1711.